SAM
BNTX icon

Shell Asset Management’s BioNTech BNTX Stock Holding History

Shell Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40,610
Closed -$4.32M – 1166
2025
Q2 		$4.32M Buy
40,610
+5,398
+15% +$545K 0.15% 137
2025
Q1 		$3.21M Buy
35,212
+15,772
+81% +$1.77M 0.15% 136
2024
Q4 		$2.21M Buy
+19,440
New +$2.22M 0.1% 190

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Shell Asset Management's BNTX Position: Q3 2025 in Review

Shell Asset Management sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 40,610 shares — an estimated $4.32M sold.

Shell Asset Management first reported a position in BNTX in Q4 2024 and held it in 3 quarters. The position peaked at $4.32M in Q2 2025. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Shell Asset Management reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Shell Asset Management sold 40,610 BioNTech shares in Q3 2025, an estimated $4.32M.
  • Shell Asset Management first reported a position in BioNTech in Q4 2024 and held it in 3 quarters.
  • Shell Asset Management's BioNTech position peaked at $4.32M in Q2 2025.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.